Table 1.
Items | Evaluable Patients (n = 23) | |
---|---|---|
No. | % | |
Age (years) | ||
Median | 61.7 | |
Range | 43–78 | |
Sex | ||
Male | 8 | 34.8 |
Female | 15 | 65.2 |
Pathological type | ||
Squamous carcinoma | 12 | 52.2 |
Adenocarcinoma | 11 | 47.8 |
Pathological stage | ||
I | 8 | 34.8 |
II | 7 | 30.4 |
IIIA | 8 | 34.8 |
Lymph-node metastasis‡ | ||
Positive | 6 | 26.1 |
Negative | 17 | 73.9 |
Smoking index§ | ||
≥400 | 13 | 56.5 |
<400 | 10 | 43.5 |
Tumor free survival(months) | ||
Mean | 42.0 | |
Range | 1–60* | |
Overall survival(months) | ||
Mean | 43.6 | |
Range | 5–60* |
‡Cancer patients were pathologically confirmed and divided into lymph node metastasis positive (N1–N3), or negative (N0), respectively.
§Smoking index = daily cigarette number × year of smoking; Smoking index ≥400 is a high-risk factor of lung cancer.
*The last follow-up of tumor free survival or overall survival was 60 months.